Pimozide

Name Value
Weight 461.556 g/mol
Zinc ID ZINC4175630
Smiles Oc1nc2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
Molecular formula C28H29F2N3O
Mode of inhibition Direct STAT; Non-peptide small molecule
CAS 2062-78-4

Clinical Trials

Study title Status Conditions Link
A Clinical Trial of Pimozide in Patients With Amyotrophic Lateral Sclerosis (ALS) Recruiting ALS|Amyotrophic Lateral Sclerosis NCT03272503
Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of Schizophrenia Completed Schizophrenia|Psychotic Disorders NCT00158223
A Registry-Based Clinical Trial of Pimozide in Patients With Neuromuscular Junction Transmission Dysfunction Due to ALS Active, not recruiting Amyotrophic Lateral Sclerosis (ALS) NCT02463825
Efficacy of Pimozide Augmentation for Clozapine Partial Response Completed Schizophrenia NCT00374244
Phase II Pilot Controlled Study of Short Vs Longer Term Pimozide (Orap) Therapy in Tourette Syndrome Completed Tourette Syndrome NCT00004652
Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis Unknown status Psychosis Nos/Other NCT01765829
Aprepitant PO vs Ondansetron IV for Prevention of Postoperative Nausea and Vomiting Withdrawn Postoperative Nausea and Vomiting NCT00699894
Antipsychotic Induced Structural and Functional Brain Changes Unknown status Schizophrenia NCT02435095
Urine Drug Levels Related to Source of Water for Irrigation for Vegetable Crops Among Healthy Israeli Volunteers Completed Healthy Individuals NCT02101801
Antipsychotics and Risk of Hyperglycemic Emergencies Completed Psychotic Disorders|Schizophrenia|Schizoaffective Disorder|Bipolar Disorder|Diabetes Mellitus, Type 2 NCT02582736
Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients Completed Schizophrenia|Schizophrenia and Disorders With Psychotic Features|Schizoaffective Disorders NCT02307396
Family Intervention in Recent Onset Schizophrenia Treatment (FIRST) Completed Schizophrenia NCT02600741
Pharmacovigilance in Gerontopsychiatric Patients Terminated Dementia|Depression|Schizophrenia|Psychosomatic Disorders|Anxiety Disorders NCT02374567
YouScript IMPACT Registry Completed Adverse Drug Events|Adverse Drug Reactions|Drug Interaction Potentiation|Drug Metabolism, Poor, CYP2D6-RELATED|Drug Metabolism, Poor, CYP2C19-RELATED|Cytochrome P450 Enzyme Deficiency|Cytochrome P450 CYP2D6 Enzyme Deficiency|Cytochrome P450 CYP2C9 Enzyme Deficiency|Cytochrome P450 CYP2C19 Enzyme Deficiency|Cytochrome P450 CYP3A Enzyme Deficiency|Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant|Poor Metabolizer Due to Cytochrome P450 CYP2C19 Variant|Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant NCT02191358

Visualization

References

Publication DOI Pubmed PMCID
The STAT5 Inhibitor Pimozide Displays Efficacy in Models of Acute Myelogenous Leukemia Driven by FLT3 Mutations. Genes & cancer Erik A Nelson, Sarah R Walker, Michael Xiang, Ellen Weisberg, Michal Bar-Natan, Rosemary Barrett, Suiyang Liu, Surender Kharbanda, Amanda L Christie, Maria Nicolais, James D Griffin, Richard M Stone, Andrew L Kung, David A Frank, 3, 7-8, None, None, 10.1177/1947601912466555 10.1177/1947601912466555 23264850 PMC3527989
Distortions in developmental reporting made by parents of behaviorally disturbed children. Journal of the American Academy of Child Psychiatry S Chess, A Thomas, H G Birch, 5, 2, None, None, 10.18632/oncotarget.24698 10.18632/oncotarget.24698 5908286 PMC5908286

Vendors

Company Lnk to product
Caymanchemical https://www.caymanchem.com/product/16222/pimozide
MedKoo Biosciences https://medkoo.com/products/6518
Tocris https://www.tocris.com/products/pimozide_0937
Sigma Aldrich https://www.sigmaaldrich.com/catalog/substance/pimozide46155206278411?lang=pl&region=PL

Filter data

Compound Pimozide
Experiment types ATP-dependent luminescence assay, Average survival, Body weight, Flow cytometry- Annexin, Luciferase activity, RT-qPCR, Relative bioluminescence, Resazurin dye assay, Western Blot
Concentrations 1.00, 10.00, 15.00, 2.50, 20.00, 25.00, 3.00, 5.00, 7.50
Cell lines Ba/f3 FLT3 ITD, Ba/f3 FLT3 ITD luc+, HuT102, K562, KU812, Kit225, MV411, Reporter cell line, bone marrow mononuclear cells, lymphoma cells, peripheral blood mononuclear cells, unmutated BCR/ABL
Organisms Homo sapiens, Homo sapiens (7 healthy patients), Homo sapiens (patient 112), Homo sapiens (patient 423), Homo sapiens (patient 706), Homo sapiens (patient1), Homo sapiens (patient2), Mus musculus
Animal models NCr nude mice
STAT proteins STAT1 luc, STAT3 luc, STAT5, p-STAT5
Other BCL-2, BCL-X, BCL-xL, BCR/ABL, CIS, Cleaved caspase-3, Cyclin D1, DR4, DR5, FAS, FLT3, GAPDH, MAPK, MCL-1, MCL1, NF-κB, PIM1, TRAIL, p-BCR/ABL, p-FLT3, p-MAPK

Experiments

Compound Experiment type Investigated event Concentration Cell line Organism Animal model Stat protein Details
Pimozide Western Blot Influence on proteins 5.00 µM Ba/f3 FLT3 ITD Homo sapiens p-STAT5
Pimozide Western Blot Influence on proteins 5.00 µM Ba/f3 FLT3 ITD Homo sapiens STAT5
Pimozide Western Blot Influence on proteins 5.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide Western Blot Influence on proteins 5.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 1.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 3.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 5.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 7.50 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 10.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 1.00 µM MV411 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 3.00 µM MV411 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 5.00 µM MV411 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 7.50 µM MV411 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 10.00 µM MV411 Homo sapiens
Pimozide Western Blot Influence on proteins in presece of PKC412 5.00 µM Ba/f3 FLT3 ITD Homo sapiens p-STAT5
Pimozide Western Blot Influence on proteins in presece of PKC412 5.00 µM MV411 Homo sapiens p-STAT5
Pimozide Western Blot Influence on proteins in presece of PKC412 5.00 µM Ba/f3 FLT3 ITD Homo sapiens STAT5
Pimozide Western Blot Influence on proteins in presece of PKC412 5.00 µM MV411 Homo sapiens STAT5
Pimozide ATP-dependent luminescence assay Influence on cell viability in presence of PKC412 5.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide Flow cytometry- Annexin Influence on cell apoptosis in presence of PKC412 5.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide Western Blot Influence on protein activity in presence of sunitinib 5.00 µM Ba/f3 FLT3 ITD Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity in presence of sunitinib 5.00 µM Ba/f3 FLT3 ITD Homo sapiens STAT5
Pimozide ATP-dependent luminescence assay Influence on cell viability in presence of sunitinib 5.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide Flow cytometry- Annexin Influence on cell apoptosis in presence of sunitinib 5.00 µM Ba/f3 FLT3 ITD Homo sapiens
Pimozide Body weight Influence on tumor growth 25.00 mg/kg Ba/f3 FLT3 ITD luc+ Mus musculus NCr nude mice
Pimozide Average survival Influence on tumor growth 25.00 mg/kg Ba/f3 FLT3 ITD luc+ Mus musculus NCr nude mice
Pimozide Relative bioluminescence Influence on tumor growth 25.00 mg/kg Ba/f3 FLT3 ITD luc+ Mus musculus NCr nude mice
Pimozide Luciferase activity Influence on protein activity 1.00 µM Reporter cell line Homo sapiens STAT1 luc
Pimozide Luciferase activity Influence on protein activity 2.50 µM Reporter cell line Homo sapiens STAT1 luc
Pimozide Luciferase activity Influence on protein activity 5.00 µM Reporter cell line Homo sapiens STAT1 luc
Pimozide Luciferase activity Influence on protein activity 7.50 µM Reporter cell line Homo sapiens STAT1 luc
Pimozide Luciferase activity Influence on protein activity 10.00 µM Reporter cell line Homo sapiens STAT1 luc
Pimozide Luciferase activity Influence on protein activity 1.00 µM Reporter cell line Homo sapiens STAT3 luc
Pimozide Luciferase activity Influence on protein activity 2.50 µM Reporter cell line Homo sapiens STAT3 luc
Pimozide Luciferase activity Influence on protein activity 5.00 µM Reporter cell line Homo sapiens STAT3 luc
Pimozide Luciferase activity Influence on protein activity 7.50 µM Reporter cell line Homo sapiens STAT3 luc
Pimozide Luciferase activity Influence on protein activity 10.00 µM Reporter cell line Homo sapiens STAT3 luc
Pimozide Luciferase activity Influence on protein activity 1.00 µM Reporter cell line Homo sapiens
Pimozide Luciferase activity Influence on protein activity 2.50 µM Reporter cell line Homo sapiens
Pimozide Luciferase activity Influence on protein activity 5.00 µM Reporter cell line Homo sapiens
Pimozide Luciferase activity Influence on protein activity 7.50 µM Reporter cell line Homo sapiens
Pimozide Luciferase activity Influence on protein activity 10.00 µM Reporter cell line Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM KU812 Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM KU812 Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM KU812 Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM KU812 Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM KU812 Homo sapiens
Pimozide Western Blot Influence on protein activity 1.00 µM KU812 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 2.50 µM KU812 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 5.00 µM KU812 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 7.50 µM KU812 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM KU812 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 1.00 µM KU812 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 2.50 µM KU812 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 5.00 µM KU812 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 7.50 µM KU812 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM KU812 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM K562 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM K562 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM K562 Homo sapiens
Pimozide Western Blot Influence on protein activity 10.00 µM K562 Homo sapiens
Pimozide Western Blot Influence on protein activity 10.00 µM KU812 Homo sapiens
Pimozide Western Blot Influence on protein activity 10.00 µM KU812 Homo sapiens
Pimozide Western Blot Influence on protein activity 10.00 µM K562 Homo sapiens
Pimozide Western Blot Influence on protein activity 10.00 µM K562 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 1.00 µM KU812 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 2.50 µM KU812 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 5.00 µM KU812 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 7.50 µM KU812 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 10.00 µM KU812 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 1.00 µM K562 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 2.50 µM K562 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 5.00 µM K562 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 7.50 µM K562 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 10.00 µM K562 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability 1.00 µM bone marrow mononuclear cells Homo sapiens (patient1)
Pimozide ATP-dependent luminescence assay Influence on cell viability 2.50 µM bone marrow mononuclear cells Homo sapiens (patient1)
Pimozide ATP-dependent luminescence assay Influence on cell viability 5.00 µM bone marrow mononuclear cells Homo sapiens (patient1)
Pimozide ATP-dependent luminescence assay Influence on cell viability 7.50 µM bone marrow mononuclear cells Homo sapiens (patient1)
Pimozide ATP-dependent luminescence assay Influence on cell viability 10.00 µM bone marrow mononuclear cells Homo sapiens (patient1)
Pimozide ATP-dependent luminescence assay Influence on cell viability 1.00 µM bone marrow mononuclear cells Homo sapiens (patient2)
Pimozide ATP-dependent luminescence assay Influence on cell viability 2.50 µM bone marrow mononuclear cells Homo sapiens (patient2)
Pimozide ATP-dependent luminescence assay Influence on cell viability 5.00 µM bone marrow mononuclear cells Homo sapiens (patient2)
Pimozide ATP-dependent luminescence assay Influence on cell viability 7.50 µM bone marrow mononuclear cells Homo sapiens (patient2)
Pimozide ATP-dependent luminescence assay Influence on cell viability 10.00 µM bone marrow mononuclear cells Homo sapiens (patient2)
Pimozide Flow cytometry- Annexin Influence on cell viability 5.00 µM KU812 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on cell viability 1.00 µM peripheral blood mononuclear cells Homo sapiens (7 healthy patients)
Pimozide Flow cytometry- Annexin Influence on cell viability 2.50 µM peripheral blood mononuclear cells Homo sapiens (7 healthy patients)
Pimozide Flow cytometry- Annexin Influence on cell viability 5.00 µM peripheral blood mononuclear cells Homo sapiens (7 healthy patients)
Pimozide Flow cytometry- Annexin Influence on cell viability 7.50 µM peripheral blood mononuclear cells Homo sapiens (7 healthy patients)
Pimozide Flow cytometry- Annexin Influence on cell viability 10.00 µM peripheral blood mononuclear cells Homo sapiens (7 healthy patients)
Pimozide Western Blot Influence on protein activity in presence of imatinib 5.00 µM KU812 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity in presence of imatinib 5.00 µM KU812 Homo sapiens STAT5
Pimozide ATP-dependent luminescence assay Influence on cell viability in presence of imatinib 5.00 µM KU812 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on cell viability in presence of imatinib 5.00 µM KU812 Homo sapiens
Pimozide Western Blot Influence on protein activity in presence of nilotinib 5.00 µM K562 Homo sapiens
Pimozide Western Blot Influence on protein activity in presence of nilotinib 5.00 µM K562 Homo sapiens
Pimozide ATP-dependent luminescence assay Influence on cell viability in presence of nilotinib 5.00 µM K562 Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM unmutated BCR/ABL Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM unmutated BCR/ABL Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM unmutated BCR/ABL Homo sapiens
Pimozide RT-qPCR Influence on gene expression 5.00 µM unmutated BCR/ABL Homo sapiens
Pimozide Western Blot Influence on protein activity 5.00 µM Kit225 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 7.50 µM Kit225 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM Kit225 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 15.00 µM Kit225 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 20.00 µM Kit225 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 5.00 µM Kit225 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 7.50 µM Kit225 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM Kit225 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 15.00 µM Kit225 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 20.00 µM Kit225 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 5.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on protein activity 7.50 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on protein activity 10.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on protein activity 15.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on protein activity 20.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on protein activity 5.00 µM HuT102 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 7.50 µM HuT102 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM HuT102 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 15.00 µM HuT102 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 20.00 µM HuT102 Homo sapiens p-STAT5
Pimozide Western Blot Influence on protein activity 5.00 µM HuT102 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 7.50 µM HuT102 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 10.00 µM HuT102 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 15.00 µM HuT102 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 20.00 µM HuT102 Homo sapiens STAT5
Pimozide Western Blot Influence on protein activity 5.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on protein activity 7.50 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on protein activity 10.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on protein activity 15.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on protein activity 20.00 µM HuT102 Homo sapiens
Pimozide Resazurin dye assay Influence on cell viability 5.00 µM HuT102 Homo sapiens
Pimozide Resazurin dye assay Influence on cell viability 10.00 µM HuT102 Homo sapiens
Pimozide Resazurin dye assay Influence on cell viability 15.00 µM HuT102 Homo sapiens
Pimozide Resazurin dye assay Influence on cell viability 20.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 7.50 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 15.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 7.50 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 15.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 7.50 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 15.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 7.50 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 15.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM Kit225 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 5.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 10.00 µM HuT102 Homo sapiens
Pimozide Flow cytometry- Annexin Influence on TRAIL/DR4 dependent apoptosis 20.00 µM HuT102 Homo sapiens
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 112) p-STAT5
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 112) STAT5
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 112)
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 706) p-STAT5
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 706) STAT5
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 706)
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 423) p-STAT5
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 423) STAT5
Pimozide Western Blot Influence on protein activity in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 423)
Pimozide Flow cytometry- Annexin Influence on apoptosis in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 112)
Pimozide Flow cytometry- Annexin Influence on apoptosis in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 706)
Pimozide Flow cytometry- Annexin Influence on apoptosis in patient tissue 20.00 µM lymphoma cells Homo sapiens (patient 423)